The heterogeneity of exosomal populations has hindered our understanding of their biogenesis, molecular composition, biodistribution, and functions. By employing asymmetric-flow field-flow fractionation (AF4), we identified two exosome subpopulations (large exosome vesicles, Exo-L, 90-120 nm; small exosome vesicles, Exo-S, 60-80 nm) and discovered an abundant population of non-membranous nanoparticles termed “exomeres” (~35 nm). Exomere proteomic profiling revealed an enrichment in metabolic enzymes and hypoxia, microtubule and coagulation proteins and specific pathways, such as glycolysis and mTOR signaling. Exo-S and Exo-L contained proteins involved in endosomal function and secretion pathways, and mitotic spindle and IL-2/STAT5 signaling pathways, respectively. Exo-S, Exo-L, and exomeres each had unique N-glycosylation, protein, lipid, and DNA and RNA profiles and biophysical properties. These three nanoparticle subsets demonstrated diverse organ biodistribution patterns, suggesting distinct biological functions. This study demonstrates that AF4 can serve as an improved analytical tool for isolating and addressing the complexities of heterogeneous nanoparticle subpopulations.
SUMMARY Macroautophagy is a lysosomal degradative pathway essential for neuron survival. Here we show that macroautophagy requires the Alzheimer's disease (AD) - related protein, presenilin-1 (PS1). In PS1-null blastocysts, neurons from mice hypomorphic for PS1 or conditionally depleted of PS1, substrate proteolysis and autophagosome clearance during macroautophagy are prevented due to a selective impairment of autolysosome acidification and cathepsin activation. These deficits are caused by failed PS1-dependent targeting of the v-ATPase subunit to lysosomes. N-glycosylation of the V0a1 subunit, essential for its efficient ER-to-lysosome delivery, requires the selective binding of PS1 holoprotein to the unglycosylated subunit and the Sec61alpha/oligosaccharyltransferase complex. PS1 mutations causing early-onset AD produce a similar lysosomal/autophagy phenotype in fibroblasts from AD patients. PS1 is therefore essential for v-ATPase targeting to lysosomes, lysosome acidification, and proteolysis during autophagy. Defective lysosomal proteolysis represents a basis for pathogenic protein accumulations and neuronal cell death in AD and suggests novel therapeutic targets.
Altered degradation of α-synuclein (α-syn) has been implicated in the pathogenesis of Parkinson disease (PD).We have shown that α-syn can be degraded via chaperone-mediated autophagy (CMA), a selective lysosomal mechanism for degradation of cytosolic proteins. Pathogenic mutants of α-syn block lysosomal translocation, impairing their own degradation along with that of other CMA substrates. While pathogenic α-syn mutations are rare, α-syn undergoes posttranslational modifications, which may underlie its accumulation in cytosolic aggregates in most forms of PD. Using mouse ventral medial neuron cultures, SH-SY5Y cells in culture, and isolated mouse lysosomes, we have found that most of these posttranslational modifications of α-syn impair degradation of this protein by CMA but do not affect degradation of other substrates. Dopamine-modified α-syn, however, is not only poorly degraded by CMA but also blocks degradation of other substrates by this pathway. As blockage of CMA increases cellular vulnerability to stressors, we propose that dopamine-induced autophagic inhibition could explain the selective degeneration of PD dopaminergic neurons.
Chaperone-mediated autophagy (CMA) is a selective pathway for the degradation of cytosolic proteins in lysosomes. CMA declines with age because of a decrease in the levels of lysosome-associated membrane protein (LAMP) type 2A, a lysosomal receptor for this pathway. We have selectively blocked the expression of LAMP-2A in mouse fibroblasts in culture and analyzed the cellular consequences of reduced CMA activity. CMA-defective cells maintain normal rates of long-lived protein degradation by up-regulating macroautophagy, the major form of autophagy. Constitutive upregulation of macroautophagy is unable, however, to compensate for all CMA functions. Thus, CMA-defective cells are more sensitive to stressors, suggesting that, although protein turnover is maintained, the selectivity of CMA is necessary as part of the cellular response to stress. Our results also denote the existence of crosstalk among different forms of autophagy.lysosome membrane proteins ͉ lysosomes ͉ proteases ͉ protein degradation ͉ macroautophagy I n mammalian cells, three different mechanisms contribute to the degradation of intracellular components inside lysosomes (autophagy) (1, 2). Two of these mechanisms, macroautophagy and microautophagy, are high-capacity processes that allow the simultaneous sequestration of multiple cytosolic constituents (soluble proteins and organelles) and their degradation, all at once, in the lysosomal lumen (1-3). In contrast, chaperone-mediated autophagy (CMA) allows the lysosomal degradation of specific cytosolic proteins on a molecule-by-molecule basis (4, 5). The selectivity of this pathway is conferred by means of the recognition of a pentapeptide amino acid motif in the CMA substrates by a cytosolic chaperone [heat shock cognate (hsc) protein of 70 kDa] (6). The substrate-chaperone complex is targeted to the lysosomal surface, where it interacts with the lysosome-associated membrane protein (LAMP) type 2A, a lysosomal membrane receptor for this pathway (7). After unfolding (8), the substrate translocates into the lysosomal lumen, assisted by a luminal chaperone (lys-hsc70), where it is rapidly degraded (4, 5). Binding of substrate proteins to LAMP-2A is a limiting step for CMA. Levels of LAMP-2A at the lysosomal membrane are tightly controlled and constitute a regulatory mechanism for CMA (4, 5). Up-regulation of CMA occurs during prolonged nutritional stress (starvation), exposure to toxic compounds, and mild oxidative stress (9) (reviewed in refs. 4 and 5), suggesting a role for this pathway in the selective removal of abnormal or damaged proteins under these conditions. In addition, a role for CMA in antigen presentation has recently been described (10). CMA activity decreases during aging (11), and a blockage of this pathway by mutant forms of synuclein also occurs in familial forms of Parkinson's disease (PD) (12). However, because of the complexity of the phenotypes associated with both aging and PD, the direct consequences of blockage of CMA in these systems are difficult to infer.The LAMP-2 gene und...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.